» Articles » PMID: 37226086

NLRP3 Inflammasome in Peripheral Blood Monocytes As a Risk Factor for Early -onset Preeclampsia

Overview
Publisher Biomed Central
Date 2023 May 24
PMID 37226086
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: As a leading cause of pregnancy and fetal mortality, pre-eclampsia impacts about 5-8% of pregnancies globally. To date, few studies have focused on the role played by (NOD)-like receptors protein 3 (NLRP3) in peripheral blood in early-onset pre-eclampsia (PE). In this study, we investigated whether NLRP3 expression in monocytes before 20 weeks of gestation was associated with an increased risk of early-onset PE.

Methodology: During the study period from 2019 to 2021, women with singleton pregnancies were enrolled in this prospective study at the General Hospital of Northern Theater Command. A generalized additive model (GAM) and logistic regression models were applied to determine any association between NLRP3 and the risk of early-onset PE.

Results: In total, 571 and 48 subjects were included in the control and pre-eclampsia groups, respectively. The GAM and logistic regression models showed that NLRP3 was a significant factor for PE occurrence. The area under the curve, accuracy, specificity, sensitivity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.86, 0.82, 0.95, 0.72, 15.17, 0.29, and 52.0, respectively.

Conclusion: The monitoring for NLRP3 in peripheral blood may be a potential, prospectively identifying risk factor for preeclampsia.

References
1.
Guney G, Islimye Taskin M, Tokmak A . Increase of circulating inflammatory molecules in preeclampsia, an update. Eur Cytokine Netw. 2020; 31(1):18-31. DOI: 10.1684/ecn.2020.0443. View

2.
Chen Z, Wu C, Liu Y, Li H, Zhu Y, Huang C . ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway. Cell Death Dis. 2020; 11(8):698. PMC: 7443189. DOI: 10.1038/s41419-020-02912-0. View

3.
Shirasuna K, Karasawa T, Takahashi M . Role of the NLRP3 Inflammasome in Preeclampsia. Front Endocrinol (Lausanne). 2020; 11:80. PMC: 7053284. DOI: 10.3389/fendo.2020.00080. View

4.
Ozeki A, Oogaki Y, Henmi Y, Karasawa T, Takahashi M, Takahashi H . Elevated S100A9 in preeclampsia induces soluble endoglin and IL-1β secretion and hypertension via the NLRP3 inflammasome. J Hypertens. 2021; 40(1):84-93. DOI: 10.1097/HJH.0000000000002981. View

5.
Mosimann B, Pfiffner C, Amylidi-Mohr S, Risch L, Surbek D, Raio L . First trimester combined screening for preeclampsia and small for gestational age - a single centre experience and validation of the FMF screening algorithm. Swiss Med Wkly. 2017; 147:w14498. DOI: 10.4414/smw.2017.14498. View